Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CEFTRIAXONE Cause Product dose omission issue? 72 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Product dose omission issue have been filed in association with CEFTRIAXONE (Ceftriaxone). This represents 0.4% of all adverse event reports for CEFTRIAXONE.

72
Reports of Product dose omission issue with CEFTRIAXONE
0.4%
of all CEFTRIAXONE reports
30
Deaths
56
Hospitalizations

How Dangerous Is Product dose omission issue From CEFTRIAXONE?

Of the 72 reports, 30 (41.7%) resulted in death, 56 (77.8%) required hospitalization, and 29 (40.3%) were considered life-threatening.

Is Product dose omission issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CEFTRIAXONE. However, 72 reports have been filed with the FAERS database.

What Other Side Effects Does CEFTRIAXONE Cause?

Off label use (2,201) Drug ineffective (1,862) Condition aggravated (950) Dyspnoea (944) Pyrexia (843) Drug reaction with eosinophilia and systemic symptoms (793) Rash (784) Drug hypersensitivity (760) Acute kidney injury (720) Vomiting (668)

What Other Drugs Cause Product dose omission issue?

DUPILUMAB (18,189) USTEKINUMAB (9,405) GUSELKUMAB (9,267) LENALIDOMIDE (8,145) MEPOLIZUMAB (5,873) TOFACITINIB (5,646) VOXELOTOR (5,122) BELIMUMAB (4,671) SECUKINUMAB (4,572) APREMILAST (4,460)

Which CEFTRIAXONE Alternatives Have Lower Product dose omission issue Risk?

CEFTRIAXONE vs CEFTRIAXONE\CEFTRIAXONE CEFTRIAXONE vs CEFUROXIME CEFTRIAXONE vs CEFUROXIME AXETIL CEFTRIAXONE vs CELEBREX CEFTRIAXONE vs CELECOXIB

Related Pages

CEFTRIAXONE Full Profile All Product dose omission issue Reports All Drugs Causing Product dose omission issue CEFTRIAXONE Demographics